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Abstract
Background: Matricellular proteins are extracellular regulators of cellular adhesion, signaling and performing a variety of
physiological behaviors such as proliferation, migration and differentiation. Within vascular microenvironments,
matricellular proteins exert both positive and negative regulatory cues to vascular endothelium. The relative balance of
these matricellular cues is believed to be critical for vascular homeostasis, angiogenesis activation or angiogenesis
resolution. However, our knowledge of matricellular proteins within vascular microenvironments and the mechanisms by
which these proteins impact vascular function remain largely undefined. The matricellular protein lipocalin-7 (LCN7) is found
throughout vascular microenvironments, and circumstantial evidence suggests that LCN7 may be an important regulator of
angiogenesis. Therefore, we hypothesized that LCN7 may be an important regulator of vascular function.
Methodology and Principal Findings: To test this hypothesis, we examined the effect of LCN7 overexpression, recombinant
protein and gene knockdown in a series of in vitro and in vivo models of angiogenesis. We found that overexpression of
LCN7 in MB114 and SVEC murine endothelial cell lines or administration of highly purified recombinant LCN7 protein
increased endothelial cell invasion. Similarly, LCN7 increased angiogenic sprouting from quiescent endothelial cell
monolayers and ex vivo aortic rings. Moreover, LCN7 increased endothelial cell sensitivity to TGF-b but did not affect
sensitivity to other pro-angiogenic growth factors including bFGF and VEGF. Finally, morpholino based knockdown of LCN7
in zebrafish embryos specifically inhibited angiogenic sprouting but did not affect vasculogenesis within injected embryos.
Conclusions and Significance: No functional analysis has previously been performed to elucidate the function of LCN7 in
vascular or other cellular processes. Collectively, our results show for the first time that LCN7 is an important pro-angiogenic
matricellular protein of vascular microenvironments.
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Introduction
The control of angiogenesis is highly dependent on proper cues
from the vascular microenvironment [1,2]. Vascular microenviron-
ments contain a host of factors including growth factors, cytokines
and matricellular proteins which serve as critical extracellular
integrators between structural and cellular activities [3]. By
extension, perturbations of vascular microenvironments provoke
major changes in vascular homeostasis including angiogenic
activation and resolution [4]. In particular, tumor microenviron-
ments are highly angiogenic and are characterized by altered
expression of pro-angiogenic matricellular proteins. Understanding
how the matricellular composition of tumor microenvironments is
manipulated to enhance tumor angiogenesis is of central impor-
tance to understanding how to starve tumors of blood thus realizing
the potential of anti-angiogenic approaches to cancer therapy.
Lipocalin-7 (LCN7, also Tinagl1-Tubulointerstitial nephritis
antigen like 1, Tin-ag-RP-Tubulointerstitial nephritis antigen
related protein, AZ-1-Adrenocortical zonation factor 1, and
ARG1-Androgen regulated gene 1) is a matricellular protein that
belongs to the diverse family of lipocalin proteins [5] and is highly
conserved between species. LCN7 has been shown to be
predominantly localized to vascular tissues in a variety of organ
types. For example, LCN7 is abundant in vascular smooth muscle
[6], lung capillary endothelium [7], uterine capillaries during the
postimplantation period [8], vascular basement membranes of
adrenocortical sinusoidal capillaries [9] and glomerular basement
membranes [6]. In addition, LCN7 expression has been linked to a
variety of physiological stimuli including testosterone signaling in
the mouse prostate [10] and Hif1a activation in mouse brain [11].
Most recently it was also discovered that LCN7 is differentially
regulated during angiogenesis [12]. Collectively, these findings
demonstrate that LCN7 is found within vascular microenviron-
ments and is differentially regulated during angiogenesis suggest-
ing that LCN7 may be involved with regulation of vascular
function. Despite this correlative evidence, there has been no
direct attempt to assess the function of LCN7 in vascular function
and angiogenesis.
Herein we show that LCN7 is a positive regulator of
angiogenesis that increases endothelial cell invasion, angiogenic
cell sprouting and sensitivity to TGF-b. Moreover, we demonstrate
that LCN7 is important for early angiogenesis in zebrafish
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proangiogenic matricellular protein.
Results
Overexpression of LCN7 in endothelial cell lines
LCN7 is consistently localized to vascular tissues [7,8,9,13], has
been linked to Hif1a activation in hypoxic brain damage [11] and
was previously shown to be differentially expressed during
endothelial cell angiogenesis on Matrigel matrices [12]. However,
the functional role of LCN7 in vascular function and/or
angiogenesis has not been addressed. Therefore, we set out to
determine if LCN7 may be important for angiogenesis. To
undertake this project, we first used a retroviral overexpresson
strategy to drive LCN7 protein expression in mouse brain
microcapillary endothelial (MB114) cells [14] and tumor derived
SVEC4-10 (SVEC) endothelial cells [15]. The murine LCN7
cDNA was PCR amplified with oligonucleotides engineered to
append a C-terminal FLAG epitope and subsequently cloned into a
retroviral vector (pMSCV). MB114 and SVEC cell lines were
transduced with LCN7 encoding pMSCV viral particles or empty,
control viral particles. Polyclonal populations of cells harboring
integrated sequences were selected with puromycin and tested for
overexpression of FLAG-tagged LCN7. Conditioned media from
the resulting overexpressing and control cell lines was collected,
precipitated with TCA/DOC and analyzed by western blot with
anti-FLAG M2 monoclonal antibodies. As shown in Figure 1A,
both MB114 and SVEC cells expressed and secreted FLAG-tagged
LCN7 protein. Overexpressed LCN7 migrated as a single 50 kD
band suggesting that the overexpressed protein was not glycosylated
as previously observed [16]. Weattemptedtocompare the degreeof
LCN7 protein overexpression to basal LCN7 expression using
commercially available LCN7 antibodies, however these antibody
preparations demonstrated significant non-specific binding and
failed to detect overexpressed protein much less endogenous LCN7
(data not shown). Instead, we used RT-PCR analysis to compare
relative levels of LCN7 mRNA in control and overexpressing cells.
We found that SVEC cells but not MB114 cells express low levels of
endogenous LCN7 mRNA and that overexpression significantly
increased LCN7 mRNA over basal levels in both cell lines (Fig. 1B).
Collectively these results demonstrated that we successfully
overexpressed LCN7 and allowed us to next examine the effect of
LCN7 on several in vitro models of angiogenesis.
Overexpression of LCN7 promotes pro-angiogenic
endothelial cell behaviors
Angiogenesis is characterized by several distinct endothelial cell
activities including endothelial cell proliferation, invasion through
vascular basement membranes and sprouting from quiescent
monolayers [17]. To measure the effect of LCN7 overexpression
on these processes, we used a series of in vitro models that
recapitulate these angiogenic activities. Transwell assays were first
used to monitor the effect of LCN7 on endothelial cell invasion
through artificial basement membranes (i.e. matrigel). As shown in
Figure 2A, overexpression of LCN7 significantly increased both
MB114 and SVEC endothelial cell invasion through Matrigel
coated Boyden chambers as compared to respective control
counterpart cells. We next examined the effect of LCN7 on
anigogenic sprouting from quiescent MB114 endothelial mono-
layers that had been overlayed with rat tail collagen. This assay is
designed to recapitulate the events that occur when quiescent
vasculature encounters collagen I outside the vascular basement
membrane during a wound healing process. As shown in
Figure 2B, LCN7 overexpression significantly increased MB114
endothelial cell sprouting from quiescent monolayers into the
collagen gel as compared to control cells. Finally, we used WST1
to measure the proliferation rates of control or LCN7-overex-
pressing MB114 and SVEC cells over a timecourse of three days in
complete growth media. As shown in Figure 2C, overexpression of
LCN7 did not have a significant impact on either MB114 or
SVEC endothelial cell proliferation. Collectively, these results
demonstrated for the first time that LCN7 promotes endothelial
cell invasion and sprouting and suggest that LCN7 is a pro-
angiogenic protein of the extracellular matrix (ECM).
Figure 1. Overexpression of LCN7 in endothelial cells. Murine LCN7 cDNAs were C-terminally FLAG tagged and overexpressed from pMSCV
retroviral vectors in MB114 and SVEC murine endothelial cell lines. A. Conditioned media from empty retroviral control cells (PURO) and LCN7-
overexpressing cells was precipitated with TCA/DOC, fractionated through SDS-PAGE gels and western blotted with anti-FLAG monoclonal antibodies.
Shown are representative images from a single experiment that was conducted twice with identical results. B. RT-PCR analysis was performed on either
reverse transcribed (+RT) or non-reverse transcribed (-RT) RNA pools with oligonucleotides designed to amplify LCN7 (469 bp fragment) or GAPDH
(237 bpfragment)asaloadingcontrol.Shownarerepresentativeimagesfromasingleexperimentthat wasconductedthreetimeswithidenticalresults.
doi:10.1371/journal.pone.0013905.g001
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Endothelial cell activationbygrowthfactorstimulationisan early
and critical aspect of angiogenesis activation. To begin dissecting
the molecular mechanism by which LCN7 might promote
angiogenesis, we first examined the activation ERK1/2 MAPK in
LCN7-overexpressing cells and control cells after stimulation with
various pro-angiogenic growth factors including VEGF, bFGF, and
TGF-b. As shown in Figure 3, LCN7 overexpression significantly
increased TGF-b induced phosphorylation of ERK1/2 MAPK.
However, LCN7didnothavea significanteffectonVEGF orbFGF
induced ERK1/2 phosphorylation (data not shown). The precise
mechanism by which TGF-b regulates angiogenesis remains the
subject of much debate, however, it is generally accepted that TGF-
b can have both pro- and anti-angiogenic activities and that these
activities are mediated by differential activation of the ALK5-
SMAD2/3 and ALK1-SMAD1/5/8 signal transduction pathways
[18]. Therefore,we monitoredTGF-b mediatedphosphorylationof
SMAD2 and SMAD5 in the presence or absence of LCN7 to
further investigate the coupling of LCN7 and TGF-b in endothelial
cells. As shown in Figure 3, LCN7 overexpression coupled TGF-b
to the phosphorylationof SMAD2 but not to the phosphorylationof
SMAD5. These results suggested that LCN7 may promote
angiogenesis by enhancing endothelial cell sensitivity to TGF-b
mediated ERK1/2 and SMAD2/3 signaling pathways.
To determine if enhanced TGF-b sensitivity in LCN7
overexpressing cells was functionally related to the pro-angiogenic
activity of LCN7, we performed invasion and angiogenic cell
sprouting assays in the presence of TGF-b or the TGF-b inhibitor
SB431542. As shown in Figure 3C and 3D, the addition of TGF-b
(5 ng/ml) to invading or sprouting cultures of control or LCN7
overexpressing MB114 cells provoked an increase in cellular
invasion and sprouting. Consistent with our previous results,
LCN7 overexpressing cells were more sensitive than control cells
to the pro-invasive and pro-sprouting impact of TGF-b.
Importantly, blockade of TGF-b signaling by 10 mM SB431542
reduced the enhanced invasion and sprouting activity of LCN7
overexpressing cells down to control levels. These results provided
strong evidence that LCN7 promotes angiogenesis at least in part
by sensitizing cells to the pro-angiogenic activity of TGF-b.
Recombinant LCN7 mediates endothelial cell adhesion,
invasion, and sprouting
It was important to confirm that the pro-angiogenic effects of
LCN7 were not dependent on retroviral overexpression and to
confirm that LCN7 exhibits pro-angiogenic activity in other
models of angiogenesis. To accomplish this, we used a combina-
tion of Ni+ agarose and anti-FLAG M2 affinity chromatography
to purify murine recombinant 6-His and FLAG tagged LCN7
from E. coli cell lysates. As shown in Figure 4A, recombinant
LCN7 preparations were free of contaminating proteins, had a
molecular mass of approximately 50 kD, and were reactive with
anti-FLAG antibodies. Having purified LCN7 protein, we set out
to confirm the pro-angiogenic activity of LCN7 on endothelial cell
adhesion, invasion and angiogenic sprouting.
Integrins serve as critical cell surface proteins that transmit
signals from the extracellular matrix to the cell. Ligation of
angiogenic integrins is an important aspect by which many
matricellular proteins support endothelial cell adhesion and
angiogenesis. LCN7 was previously shown to mediate adrenocor-
tical, vascular smooth muscle and 293T cell adhesion [9], but
endothelial cell adhesion to LCN7 has not previously been
demonstrated. Therefore, we compared endothelial cell adhesion
to either diluted matrigel as a positive control, BSA as a negative
control, or purified LCN7 protein. Both MB114 and SVEC
endothelial cells successfully adhered and spread out when
cultured on both matrigel and recombinant LCN7 but failed to
adhere to BSA (Fig. 4B).
Our previous results demonstrated that overexpression of LCN7
increased endothelial cell invasion and sprouting. Therefore, we
also tested our recombinant preparations for similar pro-angiogenic
activities. As shown in Figure 4C, addition of 1 mg/ml of purified
LCN7 increased MB114 and SVEC invasion through matrigel
coated boyden chambers. Moreover, inclusion of 1 mg/ml of
recombinant LCN7 into collagen overlays also stimulated endothe-
lial cell sprouting from quiescent MB114 monolayers. Finally, we
tested the ability of recombinant LCN7 to induce angiogenic
sprouting from ex vivo sections of mouse aortic rings. As shown in
Figure 4E, collagen gels supplemented with 1 mg/ml of rLCN7
provoked more angiogenic sprouting from ex vivo aortic ring sections
Figure 2. LCN7 increases endothelial cell angiogenic activities. A. Control (PURO) and LCN7-overexpressing endothelial cells cultured onto
Matrigel coated trans-wells were induced to invade towards a 2% FBS gradient for 48 hours. Invading cells were stained with crystal violet and
quantified by densitometry. Data is reported as average fold increase +/2 SE of four independent experiments. B. Quiescent monolayers of control
and LCN7-overexpressing MB114 endothelial cells were overlayed with a mixture of rat tail collagen and EGM2 media to induce angiogenic cell
sprouting. Data was collected by manually counting the number of sprouting cells in 10 high power fields and is presented as the average fold
increase +/2 SE of three independent experiments. C. Control and LCN7-overexpressing cells seeded into tissue culture plates and cell proliferation
was monitored daily for three sequential days with WST1. Data is represented as the fold increase +/2 SE compared to each cell lines first
measurement. For all panels, * indicates p,.05, Students t-test.
doi:10.1371/journal.pone.0013905.g002
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tively, these data confirmed that LCN7 promotes angiogenic cell
behaviors in a variety of cell and culture systems. Based on these in
vitro results, we set out to determine if LCN7 performs similar pro-
angiogenic functions in vivo.
Knockdown of LCN7 in zebrafish causes vascular defects
Zebrafish models of angiogenesis have become important tools
to examine the function of angiogenic genes in in vivo settings. In
particular, zebrafish strains expressing GFP from the endothelial
specific Fli1 promoter facilitate microangiogram analysis of even
the earliest vascular beds in zebrafish embryos [19,20]. Moreover,
the ability to use anti-sense morpholinos (MO) to temporarily
knockdown gene expression allows for the rapid analysis of gene
function in the absence of targeted genes [21].
In order to determine if LCN7 is important for angiogenesis in
developing zebrafish, we first performed a blast search of the full
length murine LCN7 protein sequence against the zebrafish
Figure 3. LCN7 sensitizes endothelial cells to TGF-b.A . Control and LCN7-overexpressing MB114 endothelial cells were serum starved then
stimulated with 5 ng/ml of TGF-b1 for 0, 20, 40, or 80 minutes. Whole cell lysates were fractionated in SDS-PAGE and western blotted with antibodies
to detect phosphorylated ERK1/2 MAPK (P-ERK1/2) or b-actin as a loading control. Western blot results from three independent experiments were
quantified by densitometry, normalized to b-actin to control for loading differences, and are presented as the fold increase +/2 SE of unstimulated
control cells. B. Control and LCN7-overexpressing MB114 endothelial cells were stimulated as in A. Whole cell lysates were fractionated and western
blotted with antibodies against phosphorylated SMAD-2 (P-SMAD2), phosphorylated SMAD5 (P-SMAD5), or b-actin. Western blot results from three
independent experiments were quantified by densitometry, normalized to b-actin to control for loading differences, and are presented as the fold
increase +/2 SE of unstimulated control cells. C. Control or LCN7 overexpressing MB114 endothelial cells were induced to invade through matrigel
coated transwells in the presence of 5 ng/ml TGF-b (TGF) or 10 mM TGF-b antagonist SB431542 (SB) and compared to unstimulated control (C) cells.
Invading cells were stained with crystal violet and quantified by densitometry of stained invasion membranes. The experiment was performed three
times and the resulting data is presented as the fold invasion of control cells +/2 SE. D. Quiescent cultures of control or LCN7 overexpressing MB114
endothelial cells were overlayed with rat-tail collagen containing 5 ng/ml TGF-b (TGF) or 10 uM TGF-b antagonist SB431542 (SB) and compared to
unstimulated control (C) cells. Data was collected by manually counting the number of sprouting cells in 10 high power fields and is presented as the
average fold increase +/2 SE of three independent experiments. * indicates p,.05, student’s t-test.
doi:10.1371/journal.pone.0013905.g003
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PLoS ONE | www.plosone.org 4 November 2010 | Volume 5 | Issue 11 | e13905Figure 4. Recombinant LCN7 increases pro-angiogenic activities. A. Murine His-6 and FLAG-tagged LCN7 cDNA was expressed in E. coli and
purified by sequential Ni
+-agarose (left panel) and anti-FLAG M2 (right panel) affinity columns. Representative coomassie stained gels of the
purification process are shown. LCN7 was purified to apparent homogeneity. B. Tissue culture wells were coated overnight with dilute Matrigel, 1 mg/
ml of recombinant LCN7 (rLCN7), or 10 mg/ml of BSA, then all wells were blocked with 10 mg/ml BSA. Adherent SVEC and MB114 endothelial cells
were stained with crystal violet. Shown are representative images of an experiment that was performed three times. C. MB114 and SVEC cells were
cultured on Matrigel coated trans-wells with 1 mg/ml of rLCN7 or an equivalent volume of 1XPBS. Invading cells were stained with crystal violet and
quantified by densitometry of stained invasion membranes. Results are depicted as the fold increase +/2 SE compared to 1XPBS treated cells from a
total of four independent experiments. D. Quiescent MB114 endothelial cells were overlayed with rat tail collagen containing 1 mg/ml of rLCN7 or an
equivalent volume of PBS. After 48 hours, endothelial cell sprouting was quantified by manually counting the number of sprouting cells present in 10
high power microscopic fields. Results are depicted as the fold increase +/2 SE compared to PBS treated cells from a total of three independent
experiments. E. Sections of aorta from a single mouse were embedded into rat tail collagen containing either 1 mg/ml of rLCN7 or an equivalent
volume of 1XPBS. Shown are representative images of sprouting cells after 4 days of incubation from a single experiment that was performed three
times.
doi:10.1371/journal.pone.0013905.g004
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zebrafish LCN7 gene encodes a 471 aa protein with predicted
molecular weight of 53.9 kD. We used the PRALINE alignment
tool (http://www.ibi.vu.nl/programs/pralinewww/) to construct a
multiple sequence alignment of LCN7 proteins from human, rat,
mouse, cow and fish (D. rerio). Multiple sequence comparison
revealed that LCN7 was highly conserved between species over the
entire length of the protein (Fig. 5). Features of the conserved
alignment included N-terminal Somatomedin-B domain(s), inactive
pro-cathepsin B-like domains and the signature lipocalin domain.
Overall, the multiple sequence alignment revealed 79% sequence
identity between all species over the length of the entire alignment.
Before performing anti-sense morpholino knockdown of LCN7,
it was first important to determine if LCN7 mRNA is present
during early zebrafish development. To accomplish this, we used
RT-PCR to monitor LCN7 mRNA in cDNA pools generated
from 2 to 48 hour old embryos. As shown in Figure 6A, LCN7
mRNA was detectable within 8 hours after embryo fertilization
and continued to be present over the remainder of the time course.
Sequencing of the DNA fragments confirmed amplification of
LCN7 cDNA (data not shown).
We designed a splice blocking anti-sense morpholino to
transiently knockdown LCN7 expression in developing Fli1-GFP
transgenic zebrafish embryos. Control LCN7 morpholinos were
also designed with five mismatched bases and used as to control for
possible non-specific affects caused by LCN7 morpholino
injections. Fli1-GFP embryos (1 to 8 cells) were injected with 1
to 8 ng of either LCN7 antisense morpholino, LCN7 mismatched
morpholino, or with equivalent volumes of morpholino vehicle
alone (water +0.1% phenol red). As shown in Figure 6B, injection
of 1 ng of LCN7 morpholino significantly delayed the develop-
ment of intersegmental vessels (ISV) compared to embryos injected
with either mismatched morpholinos or morpholino vehicle alone.
Overall, approximately 24 hours after injection, ISV length in
vehicle injected embryos was 70+/23.7 mm. Injection of 1 ng of
LCN7 MO reduced average ISV length to 51+/24.8 mm.
Injection of 1 ng of mismatched MO did not reduce ISV
development compared to vehicle injected embryos. Moreover,
and most likely as a consequence of delayed ISV development,
dorsal longitudinal anastomatic vessel (DLAV) development was
also delayed in LCN7 injected embryos. However, development of
the aorta and the cardinal vein was unaffected indicating that
angiogenesis, not vasculogenesis, was implicated with LCN7
deletion. Importantly, no defects in body patterning were obvious
in embryos injected with up to 2 ng of morpholino solutions.
Collectively, these results suggested that delayed ISV development
was directly linked to LCN7 knockdown rather than to off-target
effects of LCN7 morpholinos.
Although LCN7 knockdown appeared to produce specific
effects on ISV development, injection of 4 ng or more of either
LCN7 morpholinos or LCN7 mismatched control morpholinos
also caused defects in body patterning and development (data not
shown). Off-target morpholino effects are p53 dependent and
simultaneous knockdown of p53 reverses these non-specific effects
on zebrafish development [22]. Therefore, as an additional control
for possible non-specific effects of LCN7 morpholino injections, we
examined ISV development in LCN7 + p53 double knockdown
embryos. To accomplish this, we injected 1 ng LCN7 morpholino
together with 1.5 fold excess p53 specific morpholino as previously
described [22]. As shown in Figure 6C, p53 co-knockdown failed
to rescue the delay in ISV development produced by LCN7
knockdown. This result confirms that vascular defects induced by
LCN7 knockdown are vascular-specific and not related to off
target effects of LCN7 morpholinos. Collectively, these results
indicate that LCN7 is essential for proper vascular function during
angiogenesis in vivo.
Discussion
Growth factors such as VEGF, bFGF, and TGF-b are some of
the most potent regulators of angiogenesis. However, growth
factor stimulation of endothelial cells alone is not sufficient to
produce blood vessels with the physiological properties required
for proper capillary function. This is illustrated by the leaky blood
vessels observed in tumors that are stimulated by abnormally high
secretions of pro-angiogenic growth factors such as VEGF [23].
Development and maintenance of a normal vascular system also
requires input from structural and matricellular proteins of the
vascular microenvironment such as LCN7. In fact, remodeling of
structural and matricellular proteins within vascular microenvi-
ronments during angiogenesis or angiostasis serve a major role in
controlling vascular function [2]. Because these proteins are so
vital for proper vascular development, function and maintenance,
their identification and characterization are necessary for pro- and
anti-angiogenic therapies to achieve the great potential predicted
by Judah Folkman and others [17,24].
LCN7 has been shown to be expressed within vascular smooth
muscle [6] and the endothelial cell lining of blood vessels [7,9].
Furthermore, LCN7 was previously linked to Hif1a activation [11]
and is differentially expressed during angiogenesis in vitro [12].
Such circumstantial observations spatially and temporally position
LCN7 to be an important regulator of angiogenesis. Despite these
observations, no functional analysis of LCN7 in angiogenesis or
any other cellular process has previously been performed. In this
study, we have used overexpression, recombinant protein and
knockdown approaches combined with both in vitro and in vivo
angiogenesis models to investigate the role of LCN7 in
angiogenesis. Our results indicate that LCN7 mediates endothelial
cell adhesion and is essential to angiogenesis in developing
zebrafish embryos. Mechanistically, we found that LCN7
promotes angiogenesis by increasing endothelial cell invasion,
sprouting and sensitivity to TGF-b.
Angiogenesis consists of a series of endothelial cell activities
including response to pro-angiogenic growth factor signals,
stimulation of cell proliferation, degradation of the vascular
basement membrane, endothelial cell sprouting, migration and
invasion of activated cells, formation of lumenized endothelial
stacks and eventually, the development of anastomoses and
capillary networks [25]. In this manuscript, we analyzed the
function of LCN7 in several of these angiogenic stages. Our data
demonstrates that both LCN7 overexpression and administration
of highly purified recombinant LCN7 proteins increases invasion
of two distinct endothelial cell lines. Moreover, we have also shown
that overexpression of LCN7 and recombinant LCN7 promote
endothelial cell sprouting from quiescent endothelial cell mono-
layers and from dissected ex vivo aortic rings.
The precise mechanism by which LCN7 promotes angiogenic
activities remains largely unknown. However, our results provide
the first evidence that LCN7 promotes angiogenesis by increasing
endothelial cell sensitivity to TGF-b, a major determinant of pro-
angiogenic signaling [18]. In support of this, we have shown that
LCN7 increases ERK1/2 phosphorylation in TGF-b treated cells
but not in cells treated with other angiogenic growth factors
(VEGF or bFGF). We also demonstrated that the pro-angiogenic
activity of TGF-b is enhanced in LCN7 overexpressing cell lines
and that blockade of TGF-b signaling eliminates the increased
invasion and angiogenic sprouting observed in LCN7 overex-
pressing MB114 endothelial cells.
LCN7 Promotes Angiogenesis
PLoS ONE | www.plosone.org 6 November 2010 | Volume 5 | Issue 11 | e13905LCN7 Promotes Angiogenesis
PLoS ONE | www.plosone.org 7 November 2010 | Volume 5 | Issue 11 | e13905Figure 6. Morpholino knockdown in zebrafish embryos. A. LCN7 expression was detected in developing zebrafish embryos by RT-PCR
analysis. cDNAs pools were generated from embryos ranging from 2 to 48 hours and subjected to RT-PCR analysis with either LCN7 or GAPDH
specific oligonucleotides. B. Freshly fertilized zebrafish embryos between 1 to 8 cells were injected with morpholino vehicle (water +.1% phenol red)
or equal volumes containing either 1 ng of LCN7 morpholino, or 1 ng of mismatched LCN7 control morpholino. Microangiogram analysis was
performed approximately 28 hours later by detecting endothelial-specific expression of GFP. The accompanying graph depicts average ISV pixel
length (converted to mM) as measured along the entire dorsal surface in each of five embryos in each experiment. Results shown are the average +/2
SE of five independent experiments. Bar equals 100 mM. C. Freshly fertilized zebrafish embryos were injected with morpholino vehicle (water +.1%
phenol red) or equal volumes containing 1 ng of LCN7 morpholinos or 1 ng of LCN7+1.5 ng of p53 morpholinos. ISV vessel length was measured as
described above and results are presented as the average +/2 SE of five independent experiments consisting of at least five individual fish per
injection. For all panels, * indicates p,.05, students t-test. Bar equals 100 mM.
doi:10.1371/journal.pone.0013905.g006
Figure 5. LCN7 is conserved between species. LCN7 protein sequences from human, rat, zebrafish, cow, and mouse were compared using
PRALINE sequence alignment tool. The degree of conservation for each amino acid is indicated by color according to the key and in the
‘‘conservation’’ line of the alignment where * indicates 100% identity. Prosite analysis predicted the location of somatoamedin B (AA 74 to 95),
lipocalin (AA 272 to 285), and cathepsin B (AA 402 to 452) and (AA 424 to 443) domains that are outlined with dashed lines. Overall, the alignment
showed 79% sequence identity over the entire length of the alignment.
doi:10.1371/journal.pone.0013905.g005
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attributed to TGF-b. However, the mechanistic rationale for this
dichotomy are the subject of ongoing debate. One perspective on
this debate is that TGF-b activation of SMAD2/3 via the ALK5
receptor is coupled to angiogenesis activation while TGF-b
activation of SMAD1/5/8 via the ALK1 receptor mediates
angiogenesis resolution [26,27,28,29]. Consistent with this model,
we have found that LCN7 increases coupling of TGF-b to
SMAD2 but not SMAD5. However, another perspective on this
debate claims that it is activation of ALK1 and SMAD1/5/8 by
TGF-b that mediates angiogenic activation and moreover that
SMAD1/5/8 activation suppresses the angiostatic effects of
SMAD2/3 activation [30,31,32]. Although it is beyond the scope
of this report, it will be critical in future research to more closely
examine the link between LCN7, TGF-b and angiogenesis to
gauge the importance of TGF-b signaling to LCN7’s pro-
angiogenic activities and to provide insight into the controversy
regarding the role of TGF-b in angiogenesis.
Our data also determined that LCN7 mediates endothelial cell
adhesion. Consistent with this finding, Li et al [9] previously
demonstrated that LCN7 promotes vascular smooth muscle cell
adhesion by binding to a1, a2, a5 and b1 integrin receptors.
Although the identity of integrin receptors involved in endothelial-
LCN7 adhesion remain unknown, all of the afore mentioned
integrin subunits are expressed in endothelial cells and each of the
possible combinations (i.e. a1b1, a2b1, and a5b1) are known
regulators of angiogenesis [33]. Therefore it is likely that in
addition to sensitizing endothelial cells to TGF-b, LCN7 may also
promote angiogenesis by mediating ligation of pro-angiogenic
integrins. Future studies will focus on identifying LCN7 binding
integrins in endothelial cells and determining the importance of
these interactions to LCN7’s pro-angiogenic activities.
Finally, LCN7 contains two protein domains that may provide
additional hints at the protein’s pro-angiogenic activity. First,
LCN7 is a member of the lipocalin family of extracellular matrix
proteins which is very diverse and serves a wide range of functions
[5]. Of the lipocalins, lipocalin-2 (LCN2, also neutrophil-
gelatinase associated lipocalin, NGAL) is most relevant to this
study since LCN2 suppresses angiogenesis in pancreatic cancer
[34]. Given the small size of the lipocalin domain and the
divergence of function between LCN2 and LCN7, it seems
unlikely that any general conserved angiogenic function can be
assigned to lipocalin proteins. LCN7 also contains cathepsin B-like
domains. Cathepsin B is a secreted protease of the cathepsin family
which is important for proteolytic processing of extracellular
matricies, cellular invasion, migration and are linked to various
human pathologies of the cardiovascular and other systems [35].
However, the cathepsin domains of LCN7 are not active [6,10].
This observation has led to the hypothesis that LCN7 may serve as
an inhibitor of cathepsin activity and block cell invasion and
migration. Our results do not support this hypothesis since we find
that LCN7 increases endothelial cell invasion and sprouting.
In summary, we have identified and characterized LCN7 as a
novel matricellular regulator of angiogenesis. Although we
determined that LCN7 promotes endothelial cell invasion,
sprouting and angiogenesis in vivo, there remain a significant
number of questions that remain to be addressed regarding the
biological function of LCN7. For instance, future studies need to
be performed to 1.) more precisely define the mechanism by which
LCN7 promotes angiogenesis, 2.) describe the impact of LCN7 on
additional cell types present in vascular microenvironments, and
3.) determine if LCN7 is an important regulator of angiogenesis in
various human diseases characterized by insufficient or excessive
angiogenesis.
Materials and Methods
Ethics Statement
Animal studies were performed in accordance with the animal
protocol procedures approved by the Institutional Animal Care
and Use Committee of Indiana State University (protocol #1-19-
2008:AA and 11-08-2007:AA).
Cell biological assays (proliferation, invasion, sprouting
assays)
Angiogenic sprouting of MB114 cells in collagen matrices was
performed as described previously [36]. Briefly, control- or LCN7-
overexpressing cells (400,000 cells/well) were seeded onto 6-well
plates and allowed to grow to confluence. Confluent monolayers
were overlayed with 2 ml of solidified rat tail collagen containing
10%FBS and 1X MB114 cell media. Sprouting was allowed to
proceed for 5 days, whereupon sprouting cells were visualized by
carefully focusing a 20X objective just above the plane of quiescent
endothelium to identify cells that sprouted from the monolayer
and entered the collagen matrix. The number of invading
angiogenic sprouts was quantified under a light microscope by
determining the average number of sprouts present in 10
independent fields/well.
Proliferation assays were performed by seeding 1000 control or
LCN7-overexpressing MB114 or SVEC endothelial cells into 96-
well plates in 100 ml of complete growth media. Cell proliferation
was monitored daily for 3 days by adding 10 ml of WST1 for
2 hours after which absorbance at OD450 in the conditioned
media was measured.
Invasion assays were performed using a modified Boyden-chamber
assay as described previously [36,37]. Briefly, upper chambers (8 mm
pore, 24-well format; BD Biosciences) were coated with 100 mlo f
diluted Matrigel [1:50 in serum-free DMEM (SFM)], which was
evaporated overnight at room temperature. Subsequently, control or
LCN7-overexpressing MB114 or SVEC cells were washed twice in
SFM containing 0.1% BSA (SFM/0.1% BSA) and seeded in upper
chambers at a density of 100,000 cells/well. Endothelial cell invasion
was stimulated by addition of 2% serum to lower chambers, and was
allowed to proceed for 48 h at 37uC. Invading endothelial cells were
washed, fixed in 95% ethanol, and stained with crystal violet. The
number of invading endothelial cells was determined by densitomet-
ric analysis of scanned invasion membranes.
Aortic ring assays were performed by first dissecting the aorta
from freshly sacrificed C57BL/6 mice and slicing the aorta into
approximately 1 mm thick rings. Up to 10 aortic rings isolated
from each animal were equally divided and half of each group was
imbedded into collagen gels containing 1 mg/ml of recombinant
LCN7 while the other half of each group was imbedded into
collagen gels containing an equal volume of PBS. Collagen gels
were formed by isolating rat tail collagen as previously described
[38], mixing purified collagen 1:1 with EGM2 media (clonetics)
and overlaying the solidified collagen gels with EGM2 media.
Recombinant LCN7 production and purification
Murine LCN7 was amplified and prepared for gateway cloning
into pDEST42 by a two-stage PCR reaction that was accomplish
using oligo sets that were designed to delete the first 18 amino acids
andadd anATTB1siteto the 59end whilethe FLAG epitope tag and
ATTB2 sequences were appended to the 39 end of the protein. First
59 oligo: AAAGCAGGCTTCACCATGGAGGCCCGGCGGAG-
TCGT. Second 59 oligo: GGGGACAAGTTTGTACAAAAAAG-
CAGGCTTCACCATG. First 39 oligo: CTTATCGTCGTCATC-
CTTGTAATCGTGGTGCCCCATGTCCTC. Second 39 oligo:
GGGGACCACTTTGTACAAGAAAGCTGGGTCCTTATCG-
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vector with BP clonase (Invitrogen), subsequently cloned into
pDEST42 with LR clonase (Invitrogen) and eventually sequenced
in its entirety. To produce recombinant LCN7 in BL21-DE3 cells,
LCN7 expression was induced with IPTG and the resulting protein
purified from bacterial cell lysates first on a Ni-agarose affinity
column and second on an anti-FLAG M2 affinity column using
standard procedures. Protein purity was monitored by coomassie
staining of SDS-PAGE gels.
Morpholinos and morpholino injections
The LCN7 specific anti-sense morpholino (Genetools)
(59TTAAACTCACTGGGAGGGTAGGGAG) was designed to
interfere with splicing at the LCN7 exon1 – intron1 junction. The
mismatched control LCN7 morpholino (59GTAAACGCACTGC-
GAGGGTTGGGAA) was identical to the specific LCN7 morpho-
lino except for the presence of 5 mismatched bases (underlined) that
disrupt efficient binding to the LCN7 exon1 – intron1 splice junc-
tion. Morpholinos were dissolved in water and diluted1:1 into 0.1%
phenol red/water injecting solution. Injections into 1 to 8 cell Fli1-
GFP embryos ranged from 1 to 8 ng of LCN7 morpholino in a total
volume of 0.3 to 0.6 nl per embryo. Approximately 28 hours after
fertilization, embryos were sedated in tricaine and monitored for
vascular phenotypes on a Nikon SMZ-1500 fluorescent dissecting
microscope. Morpholinos directed against p53 were synthesized
according to previously published work [22].
Plasmids and Retroviral Infections
A retroviral LCN7 vector was constructed by PCR amplifying the
full-length murine LCN7 cDNA from clone ID 3596560 (open
biosystems). To accomplish this, oligos were designed such that an
ATTB1 site was appended to the 59 end and the FLAG epitope tag
and ATTB2 sequences were appended to the 39 end through two
rounds of sequential PCR with the following oligos. First forward
LCN7 oligo: AAAGCAGGCTTCACCATGTGGGGATGTTGG-
CTG. Second forward LCN7 oligo: GGGGACAAGTTTGTA-
CAAAAAAGCAGGCTTCACCATG. First reverse LCN7 oligo:
CTACTTATCGTCGTCATCCTTGTAATCGTGGTGCCCCA-
TGTCCTC. Second reverse LCN7 oligo: GGGGACCACTTTG-
TACAAGAAAGCTGGGTCCTACTTATCGTCGTCATC. The
PCR product was cloned by BP clonase into an entry vector and
subsequently cloned with LR clonase into a custom made pMSCV
retroviral vector featuring the ATTR1-CM
r-ccdB-ATTR2 cassette
blunt cloned into the HPA1 sites of pMSCV-PURO. Clones were
selected by ampicillin resistance, tested for inserts by restriction digest
with EcoR1 and Xho1, and sequenced (Functional Genomics).
Control (i.e., pMSCV-IRES-GFP) and LCN7 retroviral super-
natants were produced and infected into murine brain microvas-
cular MB114 endothelial cells and SVEC tumor derived
endothelial cells as described previously [36,37,38,39]. Infected
cells were isolated by puromycin selections (4 mg/ml) to yield
stable polyclonal populations of control or LCN7-overexpressing
cells. LCN7 expression was confirmed by TCA/DOC precipita-
tion of conditioned media with anti-FLAG M2 monoclonal
antibodies.
Reverse-Transcription PCR
Total RNA was collected from either zebrafish embryos or from
mammalian endothelial cells using Tri Reagent (Sigma) according to
the manufacturer’s recommendations. cDNA was generated from
1 mgo ft o t a lR N At h a tw a sr e v e r s et r a n s c r i b e di n1 0mlr e a c t i o n s
according to the manufacturer’s recommendations (iScript, Biorad),
diluted to 100 ml, and used for PCR (2.5 ml cDNA/25 ml reaction).
Oligonucleotides used to amplify zebrafish LCN7 were as follows:
Forward: 59 TGCCTTACCTGGACACCATCTGTTA, Reverse:
59ACCGGTGGCCATTTCTTTCACAAG.Oligonucleotidesused
to amplify zebrafish GAPDH were as follows. 59 AGGCTTCTCA-
CAAACGAGGACACA, Reverse 59 ATCAATGACCAGTTTGC-
CGCCTTC. Oligonucleotides used to amplify mouse LCN7 were as
follows. 59 TGCCTTACCTGGACACCATCTGTTA, reverse 59
ACCGGTGGCCATTTCTTTCACAAG. Oligonucleotides used
to amplify mouse GAPDH were as follows. 59 GACAATGAA-
TACGGCTACAGCAAC, Reverse 59 GTGCAGCGAACTTTA-
TTGATGGTA. All RT-PCR products were sequenced at least once
to confirm amplification of correct target sequences.
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